These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26908439)

  • 1. The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells.
    Liu S; Yin F; Zhao M; Zhou C; Ren J; Huang Q; Zhao Z; Mitra R; Fan W; Fan M
    Oncotarget; 2016 Apr; 7(14):17920-31. PubMed ID: 26908439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma stem cells and neural stem cells respond differently to BMP4 signaling.
    Han XX; Cai C; Yu LM; Wang M; Yang W; Hu DY; Ren J; Zhu LY; Deng JJ; Chen QQ; He H; Gao Z
    Cell Regen; 2022 Nov; 11(1):36. PubMed ID: 36316503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival.
    Li Q; Wijesekera O; Salas SJ; Wang JY; Zhu M; Aprhys C; Chaichana KL; Chesler DA; Zhang H; Smith CL; Guerrero-Cazares H; Levchenko A; Quinones-Hinojosa A
    Clin Cancer Res; 2014 May; 20(9):2375-87. PubMed ID: 24789034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma stem cells involved in tumor tissue remodeling in a xenograft model.
    Dong J; Zhang Q; Huang Q; Chen H; Shen Y; Fei X; Zhang T; Diao Y; Wu Z; Qin Z; Lan Q; Gu X
    J Neurosurg; 2010 Aug; 113(2):249-60. PubMed ID: 20225923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
    Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
    Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL
    Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-ion beams effectively induce growth inhibition and apoptosis in human neural stem cells compared with glioblastoma A172 cells.
    Isono M; Yoshida Y; Takahashi A; Oike T; Shibata A; Kubota Y; Kanai T; Ohno T; Nakano T
    J Radiat Res; 2015 Sep; 56(5):856-61. PubMed ID: 26070322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.
    Rahman M; Azari H; Deleyrolle L; Millette S; Zeng H; Reynolds BA
    Future Oncol; 2013 Sep; 9(9):1389-96. PubMed ID: 23980685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
    Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
    J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
    Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
    Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Raja E; Komuro A; Tanabe R; Sakai S; Ino Y; Saito N; Todo T; Morikawa M; Aburatani H; Koinuma D; Iwata C; Miyazono K
    Oncogene; 2017 Aug; 36(35):4963-4974. PubMed ID: 28459464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
    Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
    Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma.
    Xi G; Best B; Mania-Farnell B; James CD; Tomita T
    Neoplasia; 2017 Apr; 19(4):261-270. PubMed ID: 28278424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
    Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
    Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells.
    Liu S; Yin F; Zhang J; Wicha MS; Chang AE; Fan W; Chen L; Fan M; Li Q
    J Cell Biochem; 2014 Aug; 115(8):1368-80. PubMed ID: 24519663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.